Oncology & Cancer

No SARS-CoV-2 RNA seen on surfaces in radiation oncology clinic

Testing of environmental surfaces in the radiation oncology clinic in a tertiary care COVID-19 referral center revealed no detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, according to a research ...

Inflammatory disorders

Q&A: Controlling 'inflammaging,' inflammation that occurs with aging

A team at the CRCHUM—Université de Montréal's hospital research center—has discovered a new function for proteins responsible for DNA repair in the control of an inflammatory response in aging cells, also known as senescent ...

Oncology & Cancer

Repurposing a cancer drug to reduce COVID-19 lung inflammation

Winship Cancer Institute of Emory University (Winship) and Emory investigators are testing whether an anticancer drug can reduce lung inflammation in hospitalized COVID-19 patients, possibly preventing the need for intubation ...

Oncology & Cancer

Caring for cancer patients in the COVID-19 era

In Nature Medicine, the seven comprehensive cancer centers of Cancer Core Europe (CCE), including the Netherlands Cancer Institute and Cancer Research UK Cambridge center, have shared how they rapidly reorganised their oncological ...

Oncology & Cancer

Radiotherapy for prostate cancer adjusted during COVID-19

(HealthDay)—In a special article published online April 1 in Advances in Radiation Oncology, a framework is laid out for the management of radiotherapy for prostate cancer patients during the coronavirus disease 2019 (COVID-19) ...

Medications

The pros and cons of radiotherapy: Will it work for you?

Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia's most experienced radiation oncology medical physicists.

page 9 from 40